Jaypirca® (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, Now Available in Canada for Adult Patients with Relapsed or Refractory Mantle Cell ...

Eli Lilly Canada, Inc announced today that Jaypirca® (pirtobrutinib, 100 mg & 50 mg tablets) is now approved and available for use as monotherapy for the treatment of adult patients in Canada with: ...
EuropaWire

50Hertz Secures Long-Term Offshore Grid Integration Agreement with Skyborn to Enable Gennaker Wind Farm Commissioning by 2028

Hertz and Skyborn Renewables have concluded a comprehensive cooperation agreement covering the construction and operation of two offshore substations for the Gennaker offshore wind farm, providing ...
EuropaWire

Institute of Cancer Research Leads International Effort to Define Use of Patient-Reported Outcomes in Early-Stage Cancer Trials

The Institute of Cancer Research, London, has led the development of OPTIMISE-ROR, the first structured guidance outlining how patient-reported outcomes should be used in early-stage cancer ...